Articles, App Notes, Case Studies, & White Papers

  1. Fixtures And Surrogates For Combination Product Performance Testing 5/16/2025

    The combination product market is consistently expanding. Transitioning from traditional vial systems to needle-based combination products presents several challenges that require careful consideration.

  2. Successful Industrialization Requires Solid Foundations

    Learn how choosing the appropriate quality of containment systems from the outset is critical to the successful industrialisation of an injectable drug product and review some of the associated challenges.

  3. The Road To Agile Pharmaceutical Manufacturing 7/23/2025

    Battelle helped a specialty pharma company pioneer in-package 3D printing for personalized meds—demonstrating how agile manufacturing transforms pharma production from concept to capability.

  4. Gliding Towards De-Risked Combination Product Development 3/11/2022

    Learn about the critical role plunger stoppers play in determining a combination drug product's exposure to extractables and leachables.

  5. Your Approach To USP <382> For Your Drug Product Packaging

    The USP requirements for elastomeric components of container closure systems used for parenteral products are changing. Explore the implications for vial, syringe, and cartridge container closure systems.

  6. Sustainability Considerations For Drug Delivery Device End-To-End Solutions 6/15/2022

    Learn how to address the gradual unlinking of economic activity from the consumption of finite resources and the removal of waste to support and help prevent a global climate catastrophe.

  7. Key Financial Considerations For Phase II Clinical Injectable Drug Manufacturing 9/9/2022

    This article highlights the importance of scalability and flexibility in the choice of an early-stage manufacturing strategy and how that decision impacts financial outcomes for a drug development program.

  8. Sterile Injectable Therapies: Revolutionizing Lifecycle Management

    The right balance of technical understanding, logistics, regulatory guidelines, and knowledge about product stability and quality is crucial for capitalizing on the benefits of shifting delivery formats.

  9. Customized Release Through Dispersed Dosage Formats 6/13/2024

    Typically, dosage format is based on the target product profile: how the developer envisions the product best addressing a clinical indication by maintaining population-wide efficacy.

  10. Solid Form Strategies For Increasing Oral Bioavailability

    Optimizing a drug’s solid form can improve its solubility and bioavailability when further molecular modifications are prohibitive.